Eve Costopoulos

Eve Costopoulos

Sheppard Mullin Richter & Hampton LLP

Contact
View Bio
RSS

Latest Posts › Over The Counter Drugs (OTC)

Share:

FDA’s Office of Prescription Drug Promotion Issues Its First Untitled Letter of the Year to Novartis for Misleading Statement...

On January 18, 2024, the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) issued its first untitled letter of the new year to Novartis Pharmaceuticals Corporation (Novartis)...more

2/5/2024  /  Food and Drug Administration (FDA) , Misleading Statements , OPDP , Over The Counter Drugs (OTC) , Prescription Drugs , Product Labels , Public Health , Regulatory Agenda
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide